<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Advances in Molecular Oncology</journal-id><journal-title-group><journal-title xml:lang="en">Advances in Molecular Oncology</journal-title><trans-title-group xml:lang="ru"><trans-title>Успехи молекулярной онкологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-805X</issn><issn publication-format="electronic">2413-3787</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">181</article-id><article-id pub-id-type="doi">10.17650/2313-805X-2018-5-4-117-126</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>RESEARCH ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ЭКСПЕРИМЕНТАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Exosomal proteases in colorectal cancer</article-title><trans-title-group xml:lang="ru"><trans-title>Экзосомальные протеазы при колоректальном раке</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3698-8455</contrib-id><name-alternatives><name xml:lang="en"><surname>Zambalova</surname><given-names>E. A.</given-names></name><name xml:lang="ru"><surname>Замбалова</surname><given-names>Е. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>5 Kooperativnyy Pereulok, Tomsk 634009</p></bio><bio xml:lang="ru"><p>Елена Анатольевна Замбалова.</p><p>634009 Томск, пер. Кооперативный, 5</p></bio><email>etugutova@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2865-7576</contrib-id><name-alternatives><name xml:lang="en"><surname>Patysheva</surname><given-names>M. R.</given-names></name><name xml:lang="ru"><surname>Патышева</surname><given-names>М. Р.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>5 Kooperativnyy Pereulok, Tomsk 634009</p></bio><bio xml:lang="ru"><p>634009 Томск, пер. Кооперативный, 5</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9551-1908</contrib-id><name-alternatives><name xml:lang="en"><surname>Dimcha</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Димча</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>5 Kooperativnyy Pereulok, Tomsk 634009</p></bio><bio xml:lang="ru"><p>634009 Томск, пер. Кооперативный, 5</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7774-943X</contrib-id><name-alternatives><name xml:lang="en"><surname>Tamkovich</surname><given-names>S. N.</given-names></name><name xml:lang="ru"><surname>Тамкович</surname><given-names>С. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>8 Аkad. Lavrent’eva Rpospekt, Novosibirsk 630090; 2 Pirogova St., Novosibirsk 630090</p></bio><bio xml:lang="ru"><p>630090 Новосибирск, пр-т акад. Лаврентьева, 8; 630090 Новосибирск, ул. Пирогова, 2</p></bio><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Grigor’eva</surname><given-names>A. E.</given-names></name><name xml:lang="ru"><surname>Григорьева</surname><given-names>А. Е.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>8 Аkad. Lavrent’eva Rpospekt, Novosibirsk 630090</p></bio><bio xml:lang="ru"><p>630090 Новосибирск, пр-т акад. Лаврентьева, 8</p></bio><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9122-3274</contrib-id><name-alternatives><name xml:lang="en"><surname>Kolegova</surname><given-names>E. S.</given-names></name><name xml:lang="ru"><surname>Колегова</surname><given-names>Е. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>5 Kooperativnyy Pereulok, Tomsk 634009</p></bio><bio xml:lang="ru"><p>634009 Томск, пер. Кооперативный, 5</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0907-4615</contrib-id><name-alternatives><name xml:lang="en"><surname>Kondakova</surname><given-names>I. V.</given-names></name><name xml:lang="ru"><surname>Кондакова</surname><given-names>И. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>5 Kooperativnyy Pereulok, Tomsk 634009</p></bio><bio xml:lang="ru"><p>634009 Томск, пер. Кооперативный, 5</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4701-0375</contrib-id><name-alternatives><name xml:lang="en"><surname>Afanas’ev</surname><given-names>S. G.</given-names></name><name xml:lang="ru"><surname>Афанасьев</surname><given-names>С. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>5 Kooperativnyy Pereulok, Tomsk 634009</p></bio><bio xml:lang="ru"><p>634009 Томск, пер. Кооперативный, 5</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4595-4177</contrib-id><name-alternatives><name xml:lang="en"><surname>Yunusova</surname><given-names>N. V.</given-names></name><name xml:lang="ru"><surname>Юнусова</surname><given-names>Н. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>5 Kooperativnyy Pereulok, Tomsk 634009; 2 Moskovskiy Tract, Tomsk 634050</p></bio><bio xml:lang="ru"><p>634009 Томск, пер. Кооперативный, 5; 634050 Томск, Московский тракт, 2</p></bio><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff4"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Cancer Research Institute, Тomsk National Research Medical Center of Russian Academy of Sciences</institution></aff><aff><institution xml:lang="ru">НИИ онкологии, ФГБНУ Томский национальный исследовательский медицинский центр РАН</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of Russian Academy of Sciences</institution></aff><aff><institution xml:lang="ru">ФГБУН Институт химической биологии и фундаментальной медицины Сибирского отделения РАН</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Novosibirsk National State Research University</institution></aff><aff><institution xml:lang="ru">ФГАОУ ВО Новосибирский национальный исследовательский государственный университет</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">Siberian State Medical University</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Сибирский государственный медицинский университет» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2018</year></pub-date><volume>5</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>117</fpage><lpage>126</lpage><history><date date-type="received" iso-8601-date="2019-01-04"><day>04</day><month>01</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2019-01-04"><day>04</day><month>01</month><year>2019</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, Zambalova E.A., Patysheva M.R., Dimcha A.A., Tamkovich S.N., Grigor’eva A.E., Kolegova E.S., Kondakova I.V., Afanas’ev S.G., Yunusova N.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, Замбалова Е.А., Патышева М.Р., Димча А.А., Тамкович С.Н., Григорьева А.Е., Колегова Е.С., Кондакова И.В., Афанасьев С.Г., Юнусова Н.В.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">Zambalova E.A., Patysheva M.R., Dimcha A.A., Tamkovich S.N., Grigor’eva A.E., Kolegova E.S., Kondakova I.V., Afanas’ev S.G., Yunusova N.V.</copyright-holder><copyright-holder xml:lang="ru">Замбалова Е.А., Патышева М.Р., Димча А.А., Тамкович С.Н., Григорьева А.Е., Колегова Е.С., Кондакова И.В., Афанасьев С.Г., Юнусова Н.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://umo.abvpress.ru/jour/article/view/181">https://umo.abvpress.ru/jour/article/view/181</self-uri><abstract xml:lang="en"><p><bold>The objective</bold> is to evaluate the level of ADAM10 and ADAM17 (a disintegrin and metalloproteinase) proteases, as well as 20S-proteasomes in blood plasma exosomes of patients with colorectal cancer.</p><p><bold>Materials and methods</bold>. The study included 60 patients with colorectal cancer (T2–4N0–2M0–1) and 10 control patients. The material for the study was EDTA blood plasma. Exosomes of blood plasma were isolated by ultrafiltration with ultracentrifugation. The level of tetraspanin-associated (ADAM10 and ADAM17) and tetraspanin-non-associated (20S-proteasome) proteases was evaluated by flow cytometry and Western blotting.</p><p><bold>Results.</bold> A twice negative subpopulation (ADAM10–/ADAM17–) predominated in blood plasma exosomes of colorectal cancer patients and control patients. The level of ADAM10+/ADAM17– exosomes was significantly higher in the exosomes of the plasma of control patients. There were no significant differences between the ADAM10/ADAM17 subpopulations and the 20S-proteasome level, depending on sex, age and tumor grade. A decrease in the ADAM10+/ADAM17– subpopulation was found in patients with metastatic colorectal cancer with hematogenous metastases compared with patients with T2–4N1–2M0 and 20S-proteasome compared to T2–4N0M0. A decrease in ADAM10–/ ADAM17+ exosomes and 20S-proteasomes level was found in exosomes of patients with colorectal cancer with a metabolic syndrome  in comparison with patients without metabolic disorders.</p></abstract><trans-abstract xml:lang="ru"><p/></trans-abstract><kwd-group xml:lang="en"><kwd>exosome</kwd><kwd>20S-proteasomes</kwd><kwd>the members of ADAMs family</kwd><kwd>ADAM10</kwd><kwd>ADAM17</kwd><kwd>colorectal cancer</kwd><kwd>metabolic syndrome</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>экзосома</kwd><kwd>20S-протеасома</kwd><kwd>члены семейства ADAM-протеаз</kwd><kwd>ADAM10</kwd><kwd>ADAM17</kwd><kwd>колоректальный рак</kwd><kwd>метаболический синдром</kwd></kwd-group><funding-group><funding-statement xml:lang="en">Russian Foundation for Basic Research and the government of the Tomsk region of the Russian Federation, grant № 18-415-703 006</funding-statement><funding-statement xml:lang="ru">Российский фонд фундаментальных исследований и администрации Томской области, научный проект № 18-415-703 006</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Loree J., Kopetz S. Recent developments in the treatment of metastatic colorectal cancer. Ther Adv Med Oncol 2017;9(8):551 —64. DOI: 10.1177/1758834017714997. PMID: 28794806.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Li W., Li C., Zhou T. et al. Role of exo-somal proteins in cancer diagnosis. Mol Cancer 2017;16(1):145. DOI: 10.1186/s12943-017-0706-8. PMID: 28851367.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Yunusova N.V., Tamkovich S.N., Stakhe-eva M.N. et al. The characterization of exosome from blood plasma of patients with colorectal cancer. AIP Conference Proceedings 2016;1760, № 020070.</mixed-citation></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Yunusova N.V., Tugutova E.A., Tamkovich S.N. et al. The role of exosomal tetraspanins and proteases in tumor progression. Biomeditsins-kaya khimiya = Biomedical Chemistry 2018;64(2):123—33. DOI: 10.18097/PBMC20186402123. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Юнусова Н.В., Тугутова Е.А., Тамко-вич С.Н. и др. Роль тетраспанинов и протеаз экзосом в опухолевой прогрессии. Биомедицинская химия 2018;64(2):123—33. DOI: 10.18097/PBMC20186402123.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><mixed-citation>Mathivanan S., Ji H., Simpson R.J. Exo-somes: extracellular organelles important in intercellular communication. J Proteomics 2010;73(10):1907—20. DOI: 10.1016/j.jprot.2010.06.006. PMID: 20601276.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Matthews A.L., Noy PJ., Reyat J.S. et al. Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids. Platelets 2017;28(4):333-41. DOI: 10.1080/09537104.2016.1184751. PMID: 27256961.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Lee S.B., Schramme A., Doberstein K. et al. ADAM10 is upregulated in melanoma metastasis compared with primary melanoma. J Invest Dermatol 2010;130(3):763—73. DOI: 10.1038/jid.2009.335. PMID: 19865098.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Stoeck A., Keller S., Riedle S. et al. A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44. Biochem J 2006;393(3): 609-18. DOI: 10.1042/BJ20051013. PMID: 16229685.</mixed-citation></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Yunusova N.V., Spi-rina L.V., Kondakova I.V et al. Relationship between the expression levels of PAPP-A metalloprotease and growth and transcriptional factors in endometrial cancer. Izvestiya RAN. Seriya biologicheskaya = Biology Bulletin 2013;3:284. (In Russ.) DOI:10.7868/S0002332913030119.</mixed-citation><mixed-citation xml:lang="ru">Юнусова Н.В., Спирина Л.В., Кондакова И.В. и др. Связь экспрессии металлопротеиназы PAPP-A с экспрессией ростовых и транскрипционных факторов при раке эндометрия. Известия РАН. Серия биологическая 2013;3:284. DOI:10.7868/S0002332913030119.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><mixed-citation>Kondakova I.V., Yunusova N.V., Spirina L.V. et al. Association between intracellular proteinase activities and the content of locomotor proteins in tissues of primary tumors and metastases of ovarian cancer. Bioorg Chem 2014;40(6):681-7. PMID: 25895370.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Lai R.C., Tan S.S., Teh B.J. et al. Proteolytic potential of the MSC exosome pro-teome: implications for an exosome-mediated delivery of therapeutic proteasome. E N C E S J Proteomics 2012;12:971907. DOI: 10.1155/2012/971907. PMID: 22852084.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Sharova N., Zakharova L. Multiple forms of proteasomes and their role in tumor fate. Recent Patients On Endocrine, Metabolic &amp; Immune Drug Discovery 2005;2(3):152—61.</mixed-citation></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Tamkovich S.N., Yunusova N.V., Stakheeva M.N. et al. Isolation and characterization of exosomes from blood plasma of breast cancer and colorectal cancer patients. Biomeditsins-kaya khimiya = Biomedical Chemistry 2017;63(2):165—9. (In Russ.) DOI: 10.18097/PBMC20176302165.</mixed-citation><mixed-citation xml:lang="ru">Тамкович С.Н., Юнусова Н.В., Стахе-ева М.Н. и др. Выделение и характеризация экзосом плазмы крови больных раком молочной железы и колоректальным раком. Биомедицинская химия 2017;63(2):165—9. DOI: 10.18097/PBMC20176302165.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Grigorieva A.E., Dyrkheeva N.S., Bryzgunova O.E. et al. Contamination of exosome preparations isolated from biological fluids Biomedit-sinskaya khimiya = Biomedical Chemistry 2017;63(1):91—6. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Григорьева А.Е., Дырхеева Н.С., Брыз-гунова О.Е. и др. Контаминация препаратов экзосом, выделенных из биологических жидкостей. Биомедицинская химия 2017;63(1):91—6. DOI: 10.18097/PBMC2017630191.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><mixed-citation>Tian Y., Ma L., Gong M. et al. Protein profiling and sizing of extracellular vesicles from colorectal cancer patients via flow cytometry. ACS Nano 2018;12(1):671—80. DOI: 10.1021/acsnano.7b07782. PMID: 29300458.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Silva J., Garcia V., Rodriguez M. et al. Analysis of exosome release and its prognostic value in human colorectal cancer. Genes Chromosomes Cancer 2012;51(4):409—18. PMID: 22420032.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Yoshioka Y., Kosaka N., Konishi Y. et al. Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen. Nat Commun 201;5:3591. DOI: 10.1038/ncomms4591. PMID: 24710016.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Mathews J.A., Gibb D.R., Chen B.H. et al. CD23 Sheddase A disintegrin and metalloproteinase 10 (ADAM10) is also required for CD23 sorting into B cell-derived exosomes. J Biol Chem 2010;285(48):37531 —41. DOI: 10.1074/jbc.M110.141556. PMID: 20876574.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Arduise C., Abache T., Li L. et al. Tet-raspanins regulate ADAM10-mediated cleavage of TNF-alpha and epidermal growth factor. J Immunol 2008;181(10):7002—13. PMID: 18981120.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Lopez-Verrilli M.A., Picou F., Court F.A. Schwann cell-derived exosomes enhance axonal regeneration in the peripheral nervous system. Glia 2013;61(11):1795-806. DOI: 10.1002/glia.22558. PMID: 24038411.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Groth E., Pruessmeyer J., Babendreyer A. et al. Stimulated release and functional activity of surface expressed metalloproteinase ADAM17 in exosomes. Biochim Bio-phys Acta 2016;1863(11):2795-808. DOI: 10.1016/j.bbamcr.2016.09.002. PMID: 27599715.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Zhu Y., Chen X., Pan Q.J. et al. A comprehensive proteomics analysis reveals a secretory path- and status-dependent signature of exosomes released from tumor-associated macrophages. Proteome Res 2015;14(10):4319—31. DOI: 10.1021/acs.jproteome.5b00770.</mixed-citation></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">Kondakova I.V., Spirina L.V., Koval V.D. et al. Chymotrypsin-like activity and subunit composition of proteasomes in human cancers. Molekulyarnaya biologiya = Molecular Biology 2014;48(3):384-9. (In Russ.) DOI: 10.7868/S0026898414030112.</mixed-citation><mixed-citation xml:lang="ru">Кондакова И.В., Спирина Л.В., Коваль В.Д. и др. Химотрипсинподоб-ная активность и субъединичный состав протеасом в злокачественных опухолях человека. Молекулярная биология 2014;48(3):384—9. DOI: 10.7868/S0026898414030112.</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><mixed-citation>Yunusova N.V., Kondakova I.V., Kolo-miets L.A. et al. Molecular targets for the therapy of cancer associated with metabolic syndrome (transcription and growth factors). Asia Pac J Clin Oncol 2017;14(3):134—40. DOI: 10.1111/ajco.12780. PMID: 29115033.</mixed-citation></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">Yunusova N.V., Kondakova I.V., Kolomiets L.A. et al. Serum adipokines and their receptors in endometrial and colon cancer patients: relationship with tumor progression and metastasis. Voprosy onkologii = Problems in Oncology 2015;61(4):619—23. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Юнусова Н.В., Кондакова И.В., Коломиец Л.А. и др. Адипокины и их рецепторы у больных раком эндометрия и ободочной кишки: связь с инвазией и метастазированием. Вопросы онкологии 2015;61(4):619—23.</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><mixed-citation>Yunusova N.V., Spirina L.V., Frolova A.E. et al. Association of IGFBP-6 expression with metabolic syndrome and adiponectin and IGF-IR receptor levels in colorectal cancer. Asian Pac J Cancer Prev 2016;17(8):3963—9. DOI: 10.22034/APJCP.2016.17.12.5315. PMID: 27644646.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Martinez M.C., Andriantsitohaina R. Extracellular Vesicles in Metabolic Syndrome. Circ Res 2017;120(10):1674—86. DOI: 10.1161/CIRCRESA-HA.117.309419.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Eitan E., Tosti V., Suire C.N. et al. In a randomized trial in prostate cancer patients, dietary protein restriction modifies markers of leptin and insulin signaling in plasma extracellular vesicles. Aging Cell 2017;16(6):1430—3. DOI 10.1111/acel.12657. PMID: 28921841.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Wang J., Wu Y., Guo J. et al. Adipocyte-derived exosomes promote lung cancer metastasis by increasing MMP9 activity via transferring MMP3 to lung cancer cells. Oncotarget 2017;8(47):81880—91. DOI: 10.18632/onco-target.18737. PMID: 29137230.</mixed-citation></ref></ref-list></back></article>
